国家药监局提醒:小金盾不是儿童化妆品质量认证标志

2022-03-08 人民网 网络

化妆品包装上标注“小金盾”,仅说明这个产品属于儿童化妆品,并不代表该产品已经获得监管部门审批或者质量安全得到认证。

 

儿童化妆品标志“小金盾”

2021年12月,国家药监局发布了儿童化妆品标志——“小金盾”,旨在提高儿童化妆品辨识度,保障消费者知情权。

3月7日,国家药监局在官网发文称,一些化妆品生产经营者在推销产品时,将“小金盾”标志与获得国家审批、质量认证等宣传用语相挂钩,有意混淆“小金盾”标志的涵义。

就此,国家药监局提醒广大消费者注意,“小金盾”不是产品质量认证标志。化妆品包装上标注“小金盾”,仅说明这个产品属于儿童化妆品,并不代表该产品已经获得监管部门审批或者质量安全得到认证。

“小金盾”不是产品质量认证标志

今年1月1日实施的《儿童化妆品监督管理规定》规定,儿童化妆品应当在销售包装展示面标注国家药监局规定的儿童化妆品标志(“小金盾”)。“小金盾”是儿童化妆品区别于成人化妆品、消毒产品、玩具等其他易混淆产品的区别性标志,非儿童化妆品不得标注这个标志。

国家药监局指出,需要说明的是,我国对儿童化妆品实行严格监管,主要体现在对儿童化妆品的产品配方设计、安全评估、生产条件等方面提出更高的监管要求。儿童化妆品上市前,除防晒类产品须经注册外,其他类别产品须经备案。

选购儿童化妆品请关注“小金盾”

儿童化妆品,是指适用于年龄在12岁以下(含12岁)儿童,具有清洁、保湿、爽身、防晒等功效的化妆品。通过标识“适用于全人群”“全家使用”等词语或者利用商标、图案、包装形式等暗示本化妆品使用人群包含儿童的,按照儿童化妆品管理。

国家药监局表示,依据国家药监局关于发布《儿童化妆品监督管理规定》的公告,自2022年5月1日起,申请注册或进行备案的儿童化妆品,必须标注“小金盾”;此前申请注册或进行备案的儿童化妆品,未按照规定进行标签标识的,化妆品注册人、备案人应当在2023年5月1日前完成产品标签更新。这意味着,标注“小金盾”的儿童化妆品将越来越多出现在市场上;2023年5月1日后生产或者进口的儿童化妆品将全部标注“小金盾”。

国家药监局提醒广大家长朋友,在选购儿童化妆品时,关注“小金盾”标志,同时也正确理解“小金盾”的涵义。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1301749, encodeId=18d61301e49b4, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346894, encodeId=7cb713468945a, content=<a href='/topic/show?id=75e0334e76e' target=_blank style='color:#2F92EE;'>#化妆品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33477, encryptionId=75e0334e76e, topicName=化妆品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429283, encodeId=201f142928372, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200757, encodeId=75ad1200e575e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da196447565, createdName=4nfu, createdTime=Wed Mar 09 06:42:02 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200554, encodeId=3402120055423, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=402e6541369, createdName=ms4000001052253288, createdTime=Tue Mar 08 14:33:37 CST 2022, time=2022-03-08, status=1, ipAttribution=)]
    2022-03-10 xuyu
  2. [GetPortalCommentsPageByObjectIdResponse(id=1301749, encodeId=18d61301e49b4, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346894, encodeId=7cb713468945a, content=<a href='/topic/show?id=75e0334e76e' target=_blank style='color:#2F92EE;'>#化妆品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33477, encryptionId=75e0334e76e, topicName=化妆品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429283, encodeId=201f142928372, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200757, encodeId=75ad1200e575e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da196447565, createdName=4nfu, createdTime=Wed Mar 09 06:42:02 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200554, encodeId=3402120055423, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=402e6541369, createdName=ms4000001052253288, createdTime=Tue Mar 08 14:33:37 CST 2022, time=2022-03-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1301749, encodeId=18d61301e49b4, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346894, encodeId=7cb713468945a, content=<a href='/topic/show?id=75e0334e76e' target=_blank style='color:#2F92EE;'>#化妆品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33477, encryptionId=75e0334e76e, topicName=化妆品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429283, encodeId=201f142928372, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200757, encodeId=75ad1200e575e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da196447565, createdName=4nfu, createdTime=Wed Mar 09 06:42:02 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200554, encodeId=3402120055423, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=402e6541369, createdName=ms4000001052253288, createdTime=Tue Mar 08 14:33:37 CST 2022, time=2022-03-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1301749, encodeId=18d61301e49b4, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346894, encodeId=7cb713468945a, content=<a href='/topic/show?id=75e0334e76e' target=_blank style='color:#2F92EE;'>#化妆品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33477, encryptionId=75e0334e76e, topicName=化妆品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429283, encodeId=201f142928372, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200757, encodeId=75ad1200e575e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da196447565, createdName=4nfu, createdTime=Wed Mar 09 06:42:02 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200554, encodeId=3402120055423, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=402e6541369, createdName=ms4000001052253288, createdTime=Tue Mar 08 14:33:37 CST 2022, time=2022-03-08, status=1, ipAttribution=)]
    2022-03-09 4nfu

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1301749, encodeId=18d61301e49b4, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346894, encodeId=7cb713468945a, content=<a href='/topic/show?id=75e0334e76e' target=_blank style='color:#2F92EE;'>#化妆品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33477, encryptionId=75e0334e76e, topicName=化妆品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429283, encodeId=201f142928372, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Thu Mar 10 01:30:04 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200757, encodeId=75ad1200e575e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da196447565, createdName=4nfu, createdTime=Wed Mar 09 06:42:02 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200554, encodeId=3402120055423, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=402e6541369, createdName=ms4000001052253288, createdTime=Tue Mar 08 14:33:37 CST 2022, time=2022-03-08, status=1, ipAttribution=)]
    2022-03-08 ms4000001052253288

    好的

    0